Sarepta Therapeutics
- Country
- 🇺🇸United States
- Ownership
- Private, Public
- Established
- 1980-01-01
- Employees
- 1.3K
- Market Cap
- $13.4B
- Website
- http://www.sarepta.com
- Introduction
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
- Conditions
- Interventions
- First Posted Date
- 2012-05-07
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- Sarepta Therapeutics, Inc.
- Registration Number
- NCT01593072
- Locations
- 🇺🇸
Quintiles Phase I Services, Overland Park, Kansas, United States
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers
- First Posted Date
- 2012-03-29
- Last Posted Date
- 2014-05-07
- Lead Sponsor
- Sarepta Therapeutics, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01566877
- Locations
- 🇺🇸
SNBL Clinical Pharmacology Center, Inc., Baltimore, Maryland, United States
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
- First Posted Date
- 2012-02-28
- Last Posted Date
- 2020-03-30
- Lead Sponsor
- Sarepta Therapeutics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT01540409
- Locations
- 🇺🇸
Miller Children's Hospital, Long Beach, California, United States
🇺🇸Washington University Medical School, Saint Louis, Missouri, United States
🇺🇸Summerwood Pediatrics/Infusacare Medical Services, Liverpool, New York, United States
Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients
- Conditions
- Interventions
- First Posted Date
- 2011-07-18
- Last Posted Date
- 2020-03-30
- Lead Sponsor
- Sarepta Therapeutics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT01396239
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
Safety Study of Single Administration Intravenous Treatment for Influenza
- First Posted Date
- 2011-06-20
- Last Posted Date
- 2013-06-11
- Lead Sponsor
- Sarepta Therapeutics, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT01375985
- Locations
- 🇺🇸
Covance Clinical Research Unit, Madison, Wisconsin, United States
Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
- First Posted Date
- 2011-05-12
- Last Posted Date
- 2012-05-07
- Lead Sponsor
- Sarepta Therapeutics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01353040
- Locations
- 🇺🇸
West Coast Clinical Trials, Cypress, California, United States
Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
- First Posted Date
- 2011-05-12
- Last Posted Date
- 2012-03-28
- Lead Sponsor
- Sarepta Therapeutics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01353027
- Locations
- 🇺🇸
New Orleans Center for Clinical Research - Knoxville, Knoxville, Tennessee, United States
Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients
- First Posted Date
- 2009-02-16
- Last Posted Date
- 2015-10-06
- Lead Sponsor
- Sarepta Therapeutics, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT00844597
- Locations
- 🇬🇧
Great Ormond Street Hospital, London, England, United Kingdom
🇬🇧Royal Victoria Infirmary, Newcastle Upon Tyne, England, United Kingdom
Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG)
- Conditions
- First Posted Date
- 2007-03-23
- Last Posted Date
- 2009-07-08
- Lead Sponsor
- Sarepta Therapeutics, Inc.
- Target Recruit Count
- 600
- Registration Number
- NCT00451256
Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020
- Conditions
- First Posted Date
- 2006-10-13
- Last Posted Date
- 2009-07-08
- Lead Sponsor
- Sarepta Therapeutics, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT00387283
- Locations
- 🇺🇸
NW Kinetics, Tacoma, Washington, United States